The MET receptor is frequently activated in cancer. Here, the authors show that in head and neck and lung squamous carcinoma, a polymorphic MET variant enhances binding to HER2, resulting in activation of HER2 signalling and progression of the cancers.
- Li Ren Kong
- Nur Afiqah Binte Mohamed Salleh
- Boon Cher Goh
